Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thalassemia × Alemtuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 54 Leukemia 45 Lymphoma 34 Myelodysplastic Syndromes 21 Lymphoma, Non-Hodgkin 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Hodgkin Disease 19 Leukemia, Myeloid, Acute 15 Multiple Myeloma 14 Myeloproliferative Disorders 13 Recurrence 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 9 Hematologic Neoplasms 9 Anemia, Aplastic 9 Lymphoma, T-Cell, Peripheral 8 Leukemia, Myeloid, Chronic-Phase 8 Congenital Abnormalities 8 Burkitt Lymphoma 8 Neoplasms, Plasma Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Sezary Syndrome 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, T-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

fludarabine 4 fludarabine phosphate 3 Cyclophosphamide 3 thymoglobulin 1 ruxolitinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Erythrocyte Count 1 Dexamethasone 1 Clofarabine 1 Busulfan 1 Bortezomib 1 Blood Transfusion 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡